Synthesis of the HCV Protease Inhibitor Vaniprevir (MK-7009) Using Ring-Closing Metathesis Strategy

Jongrock Kong(Merck & Co., Inc., Rahway, NJ, USA (United States)), Michael J. Zacuto(Merck & Co., Inc., Rahway, NJ, USA (United States)), Robert F. Dunn(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yang Cao(Dalian Medical University), Jacob M. Janey(Merck & Co., Inc., Rahway, NJ, USA (United States)), Sarah J. Dolman(Wiltshire College), Cheng‐yi Chen(Merck & Co., Inc., Rahway, NJ, USA (United States)), Hongmei Li(Shenyang Aerospace University), Jaume Balsells-Padros(Merck & Co., Inc., Rahway, NJ, USA (United States))
The Journal of Organic Chemistry
March 29, 2012
Cited by 67


Related Papers